Compare HCA Health Inc (HCA) vs Oracle Corporation (ORCL) Price & Performance

HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.

The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.

Oracle (ORCL) is trading at $135.56, down 6.36% over the past 24 hours amid broader market concerns about AI spending cycles and higher borrowing costs. The stock shows strong fundamental performance with three consecutive quarterly earnings beats and robust revenue growth of 21.67% net income margin for 2025. Technical indicators signal bearish momentum with the price below key resistance levels, while analyst sentiment remains overwhelmingly positive with a $236.52 consensus price target representing significant upside potential.

Oracle presents a compelling investment opportunity with strong AI cloud demand driving 120% infrastructure growth, though near-term headwinds include market volatility and aggressive capital expenditure. The company's improving debt-to-asset ratio and consistent earnings growth support long-term value, but investors should monitor execution risks in the competitive cloud infrastructure space and potential macroeconomic pressures on tech valuations.